Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Author
:
LR Baden
HM Sahly
B Essink
K Kotloff
S Frey
R Novak
D Diemert
SA Spector
N Rouphael
CB Creech
J McGettigan
S Khetan
N Segall
J Solis
A Brosz
C Fierro
H Schwartz
K Neuzil
L Corey
P Gilbert
H Janes
D Follmann
M Marovich
J Mascola
L Polakowski
J Ledgerwood
BS Graham
H Bennett
R Pajon
C Knightly
B Leav
W Deng
H Zhou
S Han
M Ivarsson
J Miller
T Zaks
Group. Study
Abstract
:

Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19.
Year of Publication
:
2021
Journal
:
The New England journal of medicine
Volume
:
384
Issue
:
5
Number of Pages
:
403-416
Date Published
:
2021
ISSN Number
:
0028-4793
URL
:
https://www.nejm.org/doi/10.1056/NEJMoa2035389?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
DOI
:
10.1056/NEJMoa2035389
Short Title
:
N Engl J Med
Download citation